에 대한 최신 뉴스 Cabaletta Bio (NASDAQ:CABA) 주식

Cabaletta Bio

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) has the potential to be applied across a broad range of autoimmune diseases.

Equities

Markets

CABA

카발레타 바이오(NASDAQ:CABA)의 주가는 수요일 24.38% 상승한 3.01달러에 마감했으며, 전신 경화증(Systemic Sclerosis) 약물 시험 업데이트 이후 시간외 거래에서 4.65% 상승한 주당 3.15달러에 거래되었다.

카발레타 바이오, 전신 경화증 약물 시험 업데이트 이후 수요일 23개월 만에 최대 급등

Cabaletta Bio Inc

Cabana Target Beta ETF

Cabana Target Drawdown 10 ETF

Cabana Target Leading Sector Moderate ETF

U.S. stocks settled higher on Friday, with the Dow Jones index gaining more than 200 points during the session. However, the index recorded losses last week.
The S&amp;P 500 recorded its worst week since September, falling 3.1% last week. The Dow declined 2.4%, while the Nasdaq Composite tumbled 3.5% during the week.
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst&#8217;s opinion to trust.
Benzinga&#8217;s Analyst Ratings API is a collection of the highest-quality stock ratings curated by the Benzinga news desk via direct partnerships with major sell-side banks. Benzinga displays overnight ratings changes on a daily basis three hours prior to the U.S. equity market opening. Data specialists at investment dashboard provider Toggle.ai recently uncovered that the analyst insights Benzinga Pro subscribers and Benzinga readers regularly receive can successfully be used as trading indicators to outperform the stock market.
Top Analyst Picks: Fortunately, any Benzinga reader can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. One of the ways traders can sort through Benzinga&#8217;s extensive database of analyst ratings is by analyst accuracy. Here&#8217;s a look at the most recent stock picks from each of the five most accurate Wall Street analysts, according to Benzinga <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock</a> Ratings.
Analyst: Jay McCanless
<ul>
<li>Analyst Firm: Wedbush</li>
<li>Ratings Accuracy: 87%</li>
<li>Latest Rating: Reiterated an Outperform rating on Landsea Homes Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSEA#NASDAQ">LSEA</a>) with a price target of $15 on March 5. This analyst sees around 108% upside in the stock.</li>
<li>Recent News: On Feb. 27, the company posted record fourth quarter home sales revenue of $450.6 million.</li>
</ul>
Analyst: Lloyd Walmsley
<ul>
<li>Analyst Firm: UBS</li>
<li>Ratings Accuracy: 86%</li>
<li>Latest Rating: Maintained a Neutral rating on Opendoor Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPEN#NASDAQ">OPEN</a>) and cut the price target from $2 to $1.2 on March 4. This analyst sees around 2% decline in the stock.</li>
<li>Recent News: On Feb. 27, Opendoor Technologies posted upbeat fourth-quarter results.</li>
</ul>
Analyst: Trevor Walsh 
<ul>
<li>Analyst Firm: Citizens Capital Markets</li>
<li>Ratings Accuracy: 85%</li>
<li>Latest Rating: Reiterated a Market Outperform rating on CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a price target of $400 on March 5. This analyst sees around 20% upside in the stock.</li>
<li>Recent News: On March 4, CrowdStrike reported fourth-quarter revenue of $1.058 billion, beating the consensus estimate of $1.032 billion.</li>
</ul>
Analyst: Josh Sullivan
<ul>
<li>Analyst Firm: Benchmark</li>
<li>Ratings Accuracy: 85%</li>
<li>Latest Rating: Reiterated a Buy rating on BlackSky Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKSY#NASDAQ">BKSY</a>) with a price target of $17 on March 7. This analyst sees around 72% upside in the stock.</li>
<li>Recent News: On March 6, BlackSky Technology reported worse-than-expected fourth-quarter financial results.</li>
</ul>
Analyst: Zachary Fadem
<ul>
<li>Analyst Firm: Wells Fargo</li>
<li>Ratings Accuracy: 85%</li>
<li>Latest Rating: Maintained an Equal-Weight rating on Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) and cut the price target from $89 to $85 on March 5. This analyst sees around 7% upside in the stock.</li>
<li>Recent News: On March 4, the company reported a fourth-quarter sales decline of 4.8% year-on-year to $13.948 billion, beating the analyst consensus estimate of $13.702 billion..</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/03/44187903/top-2-consumer-stocks-that-could-blast-off-this-quarter">Top 2 Consumer Stocks That Could Blast Off This Quarter</a></li>
</ul>

News

Price Target

Pre-Market Outlook

Analyst Ratings

Trading Ideas

BlackSky Technology Inc. Class A Common Stock

BKSY

CRWD

LSEA

OPEN

This Analyst With 85% Accuracy Rate Sees More Than 20% Upside In CrowdStrike - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts

Guidance

Franco-Nevada Expect 2025 Revenue To Be Higher Over 25% YoY, Total GEO Sales Of 465,000 to 525,000 GEO

Franco-Nevada (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNV#NYSE">FNV</a>) reported quarterly earnings of $0.95 per share which beat the analyst consensus estimate of $0.89 by 6.74 percent. This is a 5.56 percent increase over earnings of $0.90 per share from the same period last year. The company reported quarterly sales of $321.00 million which beat the analyst consensus estimate of $305.85 million by 4.95 percent. This is a 5.84 percent increase over sales of $303.30 million the same period last year.

Earnings

Earnings Beats

Franco-Nevada Q4 2024 Adj EPS $0.95 Beats $0.89 Estimate, Sales $321.00M Beat $305.85M Estimate

The establishment of a Strategic Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) Reserve and a Digital Asset Stockpile in the U.S. represents a new paradigm in the evolution of cryptocurrencies and one that could influence monetary policy in countries around the world.
While Bitcoin will have its own reserve, the Digital Asset Stockpile is expected to have Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>), Cardano (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>), and Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>), according to <a href="https://www.benzinga.com/25/03/44068814/bitcoin-ethereum-dogecoin-rally-on-trumps-strategic-crypto-reserve-announcement-cardano-xrp-solana-skyrocket-analyst-says-btcs-new-ath-possible-later-in-the-month">Trump&#8217;s earlier announcement</a>.
The connecting thread among them all? They are the largest cryptocurrencies by market capitalization. In fact, excluding stablecoins, the reserve will contain five of the top six coins in terms of valuation.
But, if it was so obvious, the next logical question is why BNB Coin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/bnb/usd">BNB</a>), the fourth-largest cryptocurrency, was not included in the reserve.
Several analysts that Benzinga spoke to blamed it on the ‘China' angle.&nbsp;
<h2 class="wp-block-heading">Ties With An &#8216;Unfriendly&#8217; Trade Partner</h2>
"President Trump's decision to omit Binance Coin from the U.S. Crypto Reserve, despite its substantial market capitalization, may well have been influenced by the ongoing trade tensions between the U.S. and China, as Binance has strong ties to China," said Shant Kevonian, CEO and founder of Web3 email platform EtherMail.
It's worth noting that Binance was initially headquartered in China but moved out before the Chinese government <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40985461/china-controls-55-of-bitcoin-hashrate-despite-crypto-ban-but-the-us-is-catching-up">restricted cryptocurrency trading</a> in the country. As of this writing, the company has no official headquarters.
See Also:<a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39359780/dogecoin-shiba-inu-floki-are-dino-coins-says-trader-he-likes-these-3-other-meme-coins-as-b?itm_source=parsely-api"> </a><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44212481/dogecoin-plunges-9-but-top-analyst-believes-meme-coin-could-stage-a-strong-rebound-in-case-this-happens">Dogecoin Plunges 9% But Top Analyst Believes Meme Coin Could Stage A &#8216;Strong&#8217; Rebound In Case This Happens</a>
Kadan Stadelmann, blockchain developer and Chief Technology Officer of Komodo Platform, also emphasized the Chinese nationality of Yi He, the company's <a href="https://www.benzinga.com/markets/cryptocurrency/24/01/36468045/changpeng-zhao-is-out-but-yi-he-stays-inside-the-unseen-power-of-binances-co-founder">little-known co-founder</a>, apart from Changpeng "CZ" Zhao.
It's not news that Trump <a href="https://www.benzinga.com/25/03/44161587/is-china-apprehensive-of-losing-the-trade-war-to-the-us-china-could-get-isolated-like-moscow-fears-xi-jinping">champions an "America First"</a> policy, placing it at the center of his political rhetoric. He has spoken about putting the U.S. at the forefront of cryptocurrency innovation and avoiding ceding the space to China.
However, the China link wasn't the only cause for concern.
<h2 class="wp-block-heading">Is BNB CZ-Tainted?</h2>
"BNB was started and majority-owned by CZ—in fact, that&#8217;s how Binance funded itself for the 2017 ICO. CZ was recently jailed by the U.S. (Biden administration) for improper KYC, so there&#8217;s no way they&#8217;d include it in a strategic reserve," said Michael Terpin, CEO of Transform Ventures and author of the book Bitcoin Supercycle.
Indeed, CZ served a four-month prison sentence <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38547115/ex-binance-ceo-changpeng-zhao-sees-crypto-industry-entering-new-phase">for anti-money laundering violations</a>, paid a $50 million fine, and stepped down from the CEO's role.&nbsp;
Moreover, according to a Forbes <a href="https://www.forbes.com/sites/javierpaz/2024/06/14/how-cryptos-richest-billionaire-doubled-his-net-worth-behind-bars/">report</a>, he owns an estimated 94 million BNB tokens, roughly 64% of the total circulating supply.
Binance has yet to respond to Benzinga's request for comment on the exclusion from the reserve.
See Also:<a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39359780/dogecoin-shiba-inu-floki-are-dino-coins-says-trader-he-likes-these-3-other-meme-coins-as-b?itm_source=parsely-api"> </a><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44212481/dogecoin-plunges-9-but-top-analyst-believes-meme-coin-could-stage-a-strong-rebound-in-case-this-happens">Dogecoin Plunges 9% But Top Analyst Believes Meme Coin Could Stage A &#8216;Strong&#8217; Rebound In Case This Happens</a>
<h2 class="wp-block-heading">Litecoin&#8217;s Privacy: The Reason Behind Exclusion?</h2>
Another popular coin whose exclusion might have surprised some was Litecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ltc/usd">LTC</a>).&nbsp;
After all, the altcoin is <a href="https://www.benzinga.com/trading-ideas/movers/25/01/43047964/litecoin-surges-12-after-analyst-says-altcoin-most-likely-to-have-next-etf-after-bitcoin-ethereum">expected to be the next exchange-traded fund</a> on Wall Street after Bitcoin and Ethereum, with characteristics deemed "very" similar to the apex cryptocurrency.
So, what happened?
Stadelmann believes a privacy-friendly update executed by the Litecoin network in 2022 could be the reason.
"Perhaps Litecoin's 2022 MimbleWimble update, which allows for private transactions where only the sender and receiver know the details, gives Trump pause," Stadelmann told Benzinga.&nbsp;
Notably, the newly added privacy features created a storm, leading to <a href="https://upbit.com/service_center/notice?id=2714">delisting</a> from South Korean cryptocurrency exchanges over conflict with the country's reporting requirements.  
In its defense. Litecoin has stated that MimbleWimble is an <a href="https://www.benzinga.com/markets/cryptocurrency/20/10/17746253/maker-cardano-litecoin-american-wrap-1012020">optional feature</a>.
A spokesperson from the Litecoin Foundation backed LTC's inclusion in a U.S. cryptocurrency reserve and expressed optimism that things could change for the better.
"We are hopeful that thoughtful consideration is given to projects that can provide long-term value for a crypto reserve, and we are confident that if a crypto reserve is passed in Congress, that Litecoin would inevitably be added, given its similar characteristics to Bitcoin and value proposition."
Photo Courtesy: Matt Fowler KC on Shutterstock.com
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44212604/peter-schiff-establishes-personal-strategic-bitcoin-reserve-vows-not-to-sell-going-down-with-the-ship-so-others-never-get-on-board">Peter Schiff Establishes Personal &#8216;Strategic Bitcoin Reserve,&#8217; Vows Not To Sell: &#8216;Going Down With The Ship So Others Never Get On Board&#8217;</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Exclusives

$ADA

$BNB

$BTC

$ETH

$LTC

$SOL

$XRP

Trump Excluded Binance Coin And Litecoin From US Crypto Reserves,  Analysts Say China, CZ's Past And Privacy Concerns Behind The Move

Brown & Brown (Europe) Ltd. Acquires 100% Of The Share Capital Of Premier Commercial Ltd; Consideration Undisclosed

BECN

QXO And Beacon Roofing Supply Confirm Discussions About Potential Combination, In Which QXO Would Acquire Beacon For $124.35 Per Share In Cash, Or ~$11B

MannKind Corporation (NASDAQ:<a href="https://www.benzinga.com/stock/MNKD#NASDAQ">MNKD</a>), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, will showcase data from recent studies of inhaled insulin across five presentations at the 18th International Conference on Advanced Technologies and Treatments for Diabetes to be held March 19-22 in Amsterdam.

MNKD

MannKind to Present New Inhaled Insulin Data at Global Diabetes Conference in Amsterdam

On March 11, Nothing will begin shipping its new Phone (3a) series, offering premium features under $500—but with a few trade-offs that budget buyers should consider.
What Happened: London-based tech startup Nothing announced the Phone (3a) and Phone (3a) Pro, priced at $379 and $459 respectively last week.
The Phone (3a) went on sale March 4 and ships starting March 11, while the (3a) Pro will be available for purchase March 11 and begins shipping March 25.
Both phones run on the Qualcomm Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) Snapdragon 7s Gen 3 processor, with 12 GB of RAM, 256 GB of storage, and 5,000 mAh batteries.
See Also:&nbsp;<a href="https://in.benzinga.com/government/regulations/25/03/44190445/palantir-delivers-ai-powered-battle-stations-to-us-army-stock-now-comparable-to-tesla-circa-2015-analyst" target="_blank" rel="noreferrer noopener">Palantir Delivers AI-Powered Battle Stations To US Army, Stock Now Comparable To Tesla Circa 2015: Analyst</a>
The 6.77-inch AMOLED displays offer up to 3,000 nits peak brightness and adaptive refresh rates from 30 to 120 Hz.
Camera hardware includes a 50-MP main sensor, 8-MP ultrawide, and a telephoto lens—2X optical zoom on the 3a, and 3X on the Pro. The Pro also upgrades the selfie camera to 50 MP.
A standout feature is the new AI-powered Essential Key, which captures screenshots or voice notes and uses the Essential Space app to extract relevant information and tasks.
However, the phones lack wireless charging and IP68 water resistance. With only IP64 certification, they can withstand rain but not submersion.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It's Important: The launch of the Phone (3a) series comes as Nothing <a href="https://www.bloomberg.com/news/articles/2025-01-16/phone-startup-nothing-raises-funding-crosses-1-billion-in-lifetime-sales">reportedly</a> seeks to raise at least $100 million in Series C funding to expand operations.
Founded in 2021 by OnePlus co-founder Carl Pei, the company is backed by Google's venture arm and iPod creator Tony Fadell.
Nothing doubled its revenue to over $500 million in 2024 and surpassed $1 billion in lifetime sales, with 7 million units sold across all product categories.
While its top markets are India, Germany, and the U.K., Nothing plans a larger U.S. expansion in 2026.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Introducing Phone (3a) Series &#x7C; Nothing TV" width="500" height="281" src="https://www.youtube.com/embed/ZizbGaSnIUE?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/03/44149586/credo-expands-hyperscaler-partnerships-with-amazon-microsoft-xai-amid-nvidia-powered-ai-boom" target="_blank" rel="noreferrer noopener">Analysts Highlight Credo Hyperscaler Partnerships With Amazon, Microsoft, xAI Amid AI Boom</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Photo courtesy: Nothing

Tech

QCOM

Nothing Launches Phone (3a), (3a) Pro With Flagship Specs Under $500: Shipping Starts March 11, But No Wireless Charging Or IP68 Rating

Synaptics&#xAE; Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYNA#NASDAQ">SYNA</a>) has extended its award-winning <a href="https://www.globenewswire.com/Tracker?data=0-1pbe1v1q0ZNJAP1GbYFqIsMSRWZaq07vlu_2CXk_LIBcaL-TWg_qltBrDtme7nams91tAt9yQQVWaDdbEIEMlIcVHx8JJKEti070yJvAg=">Veros</a>&#x2122; Triple Combo connectivity portfolio with the <a href="https://www.globenewswire.com/Tracker?data=out_mtCn-dfAigox-KNrXpp8e1fW1c62S_N1LrevI10F3JfVNus-1yYOlivq1oqeggJYA8Cf2_xfG5D_GjHPbthxo0WHqQmey4vxtmPzJOPu9f4agxGvorOFQsiqVjA0UNDyukgPWHfU19u08_0gRmWq28X0FHZ5coHTLEeHQwvNERqMdOK89kyi55-lVNIA">SYN461x</a> family of ultra-low-power (ULP) Wi-Fi&#xAE; 2.4/5/6 GHz, Bluetooth&#xAE; 6.0 and Bluetooth Low Energy (BLE), and IEEE 802.15.4 (Zigbee&#xAE;/Thread&#xAE;) systems on chip (SoCs). Designed for the embedded Edge AI Internet of Things (IoT), the SYN461x is optimized for power, system integration, size, and rapid time to market while delivering Veros' characteristic outstanding rate-over-range performance and seamless interoperability. The versatile Matter-compliant SoCs offer advanced Bluetooth features, such as Channel Sounding and LE Audio—including Auracast&#x2122;. The SYN461x specifically targets consumer and industrial applications and is tailored for devices such as wearables, smart watches, audio speakers and headsets, home appliances, security cameras, asset trackers, and factory automation.

SYNA

Synaptics Boosts Edge AI IoT With New Ultra-Low-Power Chip for Smart Homes, Audio, and Industrial Tech

Fennec Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FENC#NASDAQ">FENC</a>) reported quarterly losses of $(0.06) per share. This is a 40 percent increase over losses of $(0.10) per share from the same period last year. The company reported $7.92 million in sales this quarter. This is a 18.59 percent decrease over sales of $9.73 million the same period last year.

FENC

Fennec Pharmaceuticals Q4 2024 GAAP EPS $(0.06) Up From $(0.10) YoY, Sales $7.92M Down From $9.73M YoY

Brand Engagement Network Inc. ("BEN") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>), a global provider of conversational AI agents, has expanded its reseller partnership with Vybroo, a leader in AI-driven voice technology and division of Teleradionetworks S.A. de C.V. and Grupo Vibra Medios, a prominent radio broadcasting network in Mexico. The expanded partnership, which was initially announced in <a href="https://www.globenewswire.com/Tracker?data=MdD1hro-ZSlxjWV_lty7SraiVC59IJQAaCZo9kRdUGThq-cmAQ2BMjcS98JYDZPNGbnI2Imjp4LXvZKmB2tdHTiU8w1e73nteAi_NtQtayvZ_JgRPAia9cK6TPyP1cRAfgHv3pKLKOAneeVFzen2L3ZW6TK_J-RtbF28Dc1F-ZzzwABkqNQt957gCmQ3SlK_OkrHYet_FPmglCO6VqZz1g==">July 2024</a>, will offer AI-powered solutions across Latin America, Spain, Portugal, and Italy, strengthening BEN's presence in AI-enabled digital media through Vybroo's extensive advertising network and Grupo Siete's media platforms, unlocking new revenue opportunities in high-growth markets.
As part of the initiative, Grupo Vibra Medios and Grupo Siete, a leading Mexican media and broadcasting company that operates multiple radio stations, including Radio Disney Mexico, will deploy five AI-powered brand ambassador avatars developed by BEN to drive engagement across various platforms for its advertising clients. This pilot program will introduce QR code activations, enabling real-time consumer interactions that deliver promotions, product information, and personalized engagement.
BEN and Vybroo have also collaborated to develop an AI-powered digital persona, Roquito, modeled after Vybroo CEO and radio icon Roque Mascareño. Roquito leverages BEN's advanced conversational AI capabilities, offering businesses massively scalable, tailored engagement solutions that strengthen customer connections while optimizing costs.

BNAI

Brand Engagement Network Expands AI Partnership With Vybroo, Taps Radio Disney Mexico and Grupo Vibra to Deploy AI Brand Ambassadors Across Latin Markets

Contracts

KBR Secures Firm Fixed Price, $85M Task Award From US Air Force To Procure, Design And Deliver Critical Training Aids And Airfield Damage Repair Kits Globally

Biotech

Health Care

Financing

Offerings

General

BEAM

Beam Therapeutics Priced Underwritten Offering Of 16.15M Shares At $28.48 Per Share, And Pre-funded Warrants To Purchase 1.40M Shares At $28.47 Per Pre-funded Warrant, With Gross Proceeds Of Of Approximately $500M

Beneficient (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BENF#NASDAQ">BENF</a>) ("Beneficient," "Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform, AltAccess, today announced that it has entered into a binding agreement to settle all claims in the previously disclosed lawsuits relating to GWG Holdings, Inc. ("GWG") in federal court in the Northern District of Texas and the Bankruptcy Court for the Southern District of Texas ("GWG Litigation") against the Company, its subsidiaries, and each of their current and former directors and officers, including its founder and CEO, Brad Heppner (collectively, the "Beneficient Parties"), for a sum within applicable insurance policy limits.

Legal

BENF

Beneficient Ends Legal Battle Over GWG With Settlement, Clears Path for Focus on AltAccess Platform

Buybacks

PERI

Perion Network Board Authorizes $50M Expansion Of Prior Share Repurchase Program Of $75M Of Its Outstanding Shares, To Total Of $125M

The GEO Group, Inc. (NYSE:<a href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) ("GEO" or the "Company") announced today that U.S. Immigration and Customs Enforcement ("ICE") has entered into a contract modification of the current intergovernmental service agreement ("IGSA") for the GEO-owned, 1,328-bed Karnes ICE Processing Center (the "Center) in Karnes City, Texas to transition the Center from housing adult males only to housing mixed populations. GEO provides support services for ICE at the Center under an IGSA between Karnes County and ICE, that is effective through August 2029. GEO's support services include the exclusive use of the Center by ICE, along with security, maintenance, and food services, as well as access to recreational amenities, medical care, and legal counsel.
Under the revised IGSA, GEO is expected to generate approximately $79 million in annualized revenues in the first full year of operations, which is expected to represent incremental annualized revenues of approximately $23 million, with margins consistent with GEO's company-owned Secure Services facilities.

GEO Lands $79M Deal With ICE, Expands Karnes Facility Use and Revenue Outlook Through 2029

TRVI

Trevi Therapeutics Reports Topline Results From Its Phase 2a RIVER Trial Of Haduvio For The Treatment Of Patients With RCC (N=66); Says Haduvio Met The Primary Endpoint

<ul>
<li>Single Dose of BEAM-302 Led to Durable, Dose-dependent Increases in Total and Functional Alpha-1 Antitrypsin (AAT), Production of Corrected M-AAT, and Decreases in Mutant Z-AAT in Circulation Across Initial Three Dose Levels</li>
<li>Third Dose Level of BEAM-302 (60 mg, N=3) Achieved Mean Total AAT of 12.4µM at Day 28, Exceeding Protective Therapeutic Threshold, and Reduced Mutant Z-AAT up to 78%</li>
<li>Initial Safety Findings Demonstrated BEAM-302 was Well Tolerated at All Dose Levels with No Serious Adverse Events or Dose-Limiting Toxicities Observed</li>
<li>Clinical Profile Supports Continued Dose Escalation, with Updated Data from Part A of the Phase 1/2 Trial Expected to be Presented at Medical Conference in Second Half of 2025</li>
</ul>

Beam Therapeutics Announced Initial Safety And Efficacy Data From Its Phase 1/2 Trial Of BEAM-302, As Potential Treatment For Alpha-1 Antitrypsin Deficiency And For In Vivo Base Editing

A Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) whale accumulated about $7.5 million in unrealized profit by successfully shorting the apex cryptocurrency amid the ongoing market correction.
What Happened:&nbsp;According to an X post by on-chain tracking platform Lookonchain Sunday, the trader shorted Bitcoin at approximately $96,500 on Feb. 22 and closed the position near&nbsp;the bottom at around $78,900 six days later.
The whale&nbsp;re-entered a short position at&nbsp;the peak of approximately $94,424 following the rally induced by President Donald Trump&#8217;s executive order establishing a <a href="https://in.benzinga.com/25/03/44183572/trump-establishes-strategic-bitcoin-reserve-funded-by-forfeited-assets-i-made-the-promise">Strategic Bitcoin Reserve</a>. 
As of this writing, they have set additional short&nbsp;positions at $92,449-$92,636&nbsp;and placed limit orders to&nbsp;take profit between $70,475-$74,192.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">A whale has been very good at shorting <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> during recent price drops, with an unrealized profit of over $7.5M! On Feb 22, he shorted <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> at ~$96,500, and within a week, <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> plummeted below $80,000. He closed his short position near the bottom at ~$78,900 with perfect timing.… <a href="https://t.co/wkXOZKnU4O">pic.twitter.com/wkXOZKnU4O</a>
&mdash; Lookonchain (@lookonchain) <a href="https://twitter.com/lookonchain/status/1898911091029409835?ref_src=twsrc%5Etfw">March 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/25/03/44159088/microsoft-might-have-given-bitcoin-investments-a-miss-for-now-but-one-of-its-largest-investors-has-been-an-avid-advocate-of-cryptos-blockchains">Microsoft May Have Given Bitcoin Investments A Miss But A Large MSFT Stock Holder Is A Strong Crypto, Blockchain Advocate</a>
Why It Matters:&nbsp;The whale&#8217;s successful shorting of Bitcoin comes in the wake of the <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44212362/bitcoin-ethereum-and-dogecoin-crash-as-trump-refuses-to-rule-out-recession-arthur-hayes-predicts-btc-to-retest-78000">broader market crash</a> Sunday evening following Bitcoin&#8217;s fall to $80,000. 
Well-known Bitcoin bull Arthur Hayes predicted a retest of $78,000, with $75,000 next in line if that failed, indicating a convergence with the whale&#8217;s conviction.
The timing of several leveraged trades has sparked speculation of possible insider trading in recent days. Last week, a whale closed their 50x leveraged position on Bitcoin and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) shortly before Trump announced a&nbsp;<a href="https://www.benzinga.com/25/03/44068814/bitcoin-ethereum-dogecoin-rally-on-trumps-strategic-crypto-reserve-announcement-cardano-xrp-solana-skyrocket-analyst-says-btcs-new-ath-possible-later-in-the-month" target="_blank" rel="noreferrer noopener">cryptocurrency reserve</a>, resulting in a profit of over $6 million.
Price Action: At the time of writing, Bitcoin was exchanging hands at $81,575.36, down 5.01% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Read Next:&nbsp;
<ul>
<li><a href="https://in.benzinga.com/25/03/44183572/trump-establishes-strategic-bitcoin-reserve-funded-by-forfeited-assets-i-made-the-promise">Trump Creates Strategic Bitcoin Reserve Funded By Forfeited Assets: &#8216;I Made The Promise&#8217; — BTC Dips 4%</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Successful Bitcoin Short Trader Places Take Profit Levels Between $70,000-$74,000: Further Drop Incoming?

The unpredictable policies of President Donald Trump, especially concerning tariffs and the Russia-Ukraine conflict, have stirred a sense of uncertainty among households, businesses, and Wall Street. However, this has also paved the way for new investment opportunities, as per analysts.
What Happened: The erratic trade tactics of the Trump administration have recently led to U.S. stocks facing their toughest week of the year. Despite this, Mike Cudzil, a portfolio manager at Pimco, sees this uncertain backdrop as a breeding ground for investment opportunities, reported <a href="https://www.marketwatch.com/story/trumps-chaotic-policy-approach-is-creating-opportunity-for-investors-c7a0418d">MarketWatch</a>. He highlighted a significant shift out of Europe, particularly Germany, in anticipation of a massive fiscal package expected from Europe next week.
"What you are seeing is a repricing of risky assets in the U.S. relative to risky assets [abroad]," the portfolio manager told the publication. 
It's potentially "quite a shift in the world order" compared to the past 80 years, Cudzil added.
Friedrich Merz, likely to be Germany&#8217;s next chancellor, has pledged a massive increase in defense spending and proposed a €500 billion ($524 billion) investment in infrastructure. Cudzil attributes this potential shift to the &#8220;chaotic&#8221; U.S. policies that have prompted Europe to reconsider its defense spending. Even Goldman Sachs, researchers predict a substantial rise in defense expenditures by EU member states through 2027.
Meanwhile, the Chief Investment Officer&nbsp;at Spectrum Wealth Management, Leslie Thompson, also sees potential for profit in overseas investments. She also stated that her team has started moving some profit&nbsp;into exchange-traded funds focused on&nbsp;stocks in developed foreign markets.
SEE ALSO: <a href="https://www.benzinga.com/news/25/03/44213871/canadas-next-pm-mark-carney-vows-to-win-trade-war-with-trump-says-americans-should-make-no-mistake">Canada&#8217;s Next PM Mark Carney Vows To Win Trade War With Trump: &#8216;Americans Should Make No Mistake&#8217;</a>
Why It Matters: The economic landscape has been marked by uncertainty due to the unpredictable nature of Trump&#8217;s policies. This has led to a shift in investment strategies, with a focus on overseas markets, particularly Europe. 
Investors have recently&nbsp;poured $12 billion into European&nbsp;stocks, marking&nbsp;their strongest inflows in a&nbsp;decade. This indicates how European government stimulus could strengthen the Eurozone while the Trump administration reworks its trade agreements and aims to significantly reduce the federal government.
As noted by economist Mohamed El-Erian in a&nbsp;<a href="https://www.benzinga.com/25/03/44213521/us-economic-slowdown-talk-of-the-town-says-economist-mohamed-el-erian-as-fed-chair-powell-reaffirms-growth-at-solid-pace">podcast with Forward Guidance</a>, the risk of an economic slowdown is a significant concern. However, the current economic climate also presents opportunities for savvy investors who are willing to venture into foreign markets.
The S&amp;P 500 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) dropped 3.32% over the last five days to close at 5,770.20 on Friday, while the STOXX Europe 600 climbed 8.46% to reach 551.00.
<ul>
<li>READ MORE:<a href="https://www.benzinga.com/markets/equities/25/03/44209953/rfk-jr-takes-on-food-giants-calls-meeting-with-pepsico-and-general-mills"> RFK Jr. Takes On Food Giants: Calls Meeting With PepsiCo And General Mills</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Trump's 'Chaotic' Policies May Drive Investors To Europe, Says Analyst: 'Quite A Shift In The World Order'

Press Releases

Cabaletta Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference

Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update

Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024

Cabaletta Bio to Participate in Upcoming Investor Conferences in December

Cabaletta Bio Outlines Strategic Priorities and Anticipated Key Milestones for 2025

Cabaletta Bio to Participate in Guggenheim's SMID Cap Biotech Conference

Cabaletta Bio Announces Presentations Featuring Updated Clinical Data on Rese-cel at Upcoming Scientific Meetings in February

Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings

UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings

Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference

Aadi Bioscience

Adagene Inc. - ADS, each representing 1.25 ordinary shares

Adagene

Adverum Biotechnologies, Inc. - Common Stock

Adverum Biotechnologies

Anixa Biosciences

Adlai Nortye Ltd. - American Depositary Shares

Adlai Nortye

Atossa Therapeutics

Avalo Therapeutics

Biomea Fusion

CAMP4 Therapeutics Corporation - Common Stock

Camp4 Therapeutics

Climb Bio

Corbus Pharmaceuticals Holdings, Inc. - Common Stock

Corbus Pharmaceuticals

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

Galectin Therapeutics Inc. - Common Stock

Galectin Therapeutics

HilleVax

TuHURA Biosciences

Immunic

Jasper Therapeutics, Inc. - Class A Common Stock

Jasper Therapeutics

Lexeo Therapeutics

Regulus Therapeutics

Skye Bioscience

SELLAS Life Sciences Group, Inc. - Common Stock

SELLAS Life Sciences Gr

Vigil Neuroscience

Vistagen Therapeutics, Inc. - Common Stock

Vistagen Therapeutics

XBiotech

Zura Bio Limited - Class A Ordinary shares

Zura Bio

HC Wainwright & Co.

Evercore ISI Group

Wells Fargo

Cantor Fitzgerald

카발레타 바이오(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CABA#NASDAQ">CABA</a>)의 주가는 수요일 24.38% 상승한 3.01달러에 마감했으며, 전신 경화증(Systemic Sclerosis) 약물 시험 업데이트 이후 시간외 거래에서 4.65% 상승한 주당 3.15달러에 거래되었다.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" class="wp-image-668671" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28004158/CANA-SHares-1024x282.png" sizes="(max-width: 1024px) 100vw, 1024px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28004158/CANA-SHares-1024x282.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28004158/CANA-SHares-300x83.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28004158/CANA-SHares-768x212.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28004158/CANA-SHares-1536x423.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28004158/CANA-SHares.png 1746w" alt="" width="1024" height="282" /></figure>
또한 읽어보세요: <a href="https://www.benzinga.com/general/market-summary/24/11/42212364/trumps-tariff-threat-to-canada-may-disrupt-oil-markets-inflate-prices-would-likely-raise-the-price-of-fuels-says-analyst">트럼프의 캐나다 관세 위협은 석유 시장을 혼란스럽게 하고 가격을 인상할 수 있다: &#8216;연료 가격을 올릴 가능성이 높다&#8217;고 분석가가 말했다</a>
무슨 일이 있었나: 이 회사는 2025년에 미국 식품의약국(FDA)와 만나 등록 임상 시험 설계에 대해 논의할 예정이라고 델브인사이트 비지니스 리서치(DelveInsight Business Research)의 성명서를 통해 발표했다.
이 보고서에 따르면, 카발레타는 2024년 미국 류마티스학회 컨버전스에서 발표된 긍정적인 임상 안전성 및 효능 데이터를 선보였다. 이 전신 경화증 치료제 임상 시험은 16명의 환자를 대상으로 진행 중이며, 2024년 11월 12일 기준으로 10명의 환자가 용량을 투여받았다.
왜 중요한가: 이 주가는 수요일에 주당 3달러를 처음으로 넘어섰고, 11월 15일 이후 처음으로 상승했다. 또한, 이 주가가 단 하루에 24% 이상 상승한 것은 2022년 12월 14일 이후 2년 만에 처음이다.
카발레타 바이오는 자가면역 질환에 대한 지속적이고 잠재적으로 치유적인 치료법을 제공하기 위해 엔지니어링된 T세포 치료제를 개발하는 데 전념하고 있다. 그들의 CABA 플랫폼에는 키메라 항원 수용체 T세포와 독자적인 키메라 자가항체 수용체 T세포가 포함되어 있으며, 자가면역 질환을 표적화하도록 설계되었다.

이미지 출처: Unsplash
다음 읽기: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/11/42186167/michael-saylors-microstrategy-convertible-notes-to-buy-bitcoin-offer-no-interest-so-why-are-investors-rushing-to-buy-them">마이클 세일러의 마이크로스트레티지 전환사채가 비트코인을 사는데 이자를 제공하지 않는데, 왜 투자자들이 몰려드는 걸까요?</a></li>
</ul>
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Cabaletta Bio

뉴스

에 대한 최신 뉴스 Cabaletta Bio (NASDAQ:CABA) 주식

목요일, 11월 28, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌